期刊文献+

胎盘生长因子和白细胞介素10水平与急性冠状动脉事件的相关性 被引量:1

The Relationship of Placenta Growth Factor and Interleukin-10 in the Risk for Cardiovascular Events of Acute Coronary Syndrome
下载PDF
导出
摘要 目的通过对急性冠状动脉综合征患者血清胎盘生长因子和白细胞介素10水平的测定,探讨其在急性冠状动脉综合征的早期预测及预后判断中的价值。方法将90例患者分为ST段抬高型急性心肌梗死组(n=26)、非ST段抬高型急性心肌梗死/不稳定型心绞痛组(n=36)、稳定型心绞痛组(n=14)和对照组(n=14)。采用ELISA法检测各组血清胎盘生长因子和白细胞介素10水平;随访并观察各组30天、90天后主要心血管事件(死亡、再梗死和紧急血运重建)的发生。结果ST段抬高型急性心肌梗死患者和非ST段抬高型急性心肌梗死/不稳定型心绞痛患者血清胎盘生长因子水平较稳定型心绞痛患者明显升高,而白细胞介素10水平显著降低(P(0.01)。具有高水平血清胎盘生长因子的患者在随访30天及90天的心血管事件发生率明显增加,而具有高水平白细胞介素10的患者心血管事件发生率明显降低。相关性分析显示,血清胎盘生长因子与白细胞介素10水平呈负相关。结论血清胎盘生长因子可能是早期预测急性冠状动脉综合征的有力指标,血清胎盘生长因子与白细胞介素10两者之间的平衡,可能是预测急性冠状动脉综合征患者预后转归的重要因素。 Aim Through the confer of concentration of placenta growth factor(PLGF) and interleukin-10 (IL-10) to explore its early prediction and prognostic value in acute coronary syndrome (ACS) patients. Methods 90 patients were divided into experimental sub-STEMI group, NSTEMI/UAP group, SAP group and control group. The concentration of PLGF and IL-10 were measured by the method of enzyme linked immunosorbent assay (ELISA). The risk of follow-up cardiovascular events were detected during 30 days and 3 months, then ...
出处 《中国动脉硬化杂志》 CAS CSCD 2008年第12期969-972,共4页 Chinese Journal of Arteriosclerosis
关键词 内科学 胎盘生长因子 白细胞介素10 急性冠状动脉综合征 Placenta Growth Factor Interleukin-10 Acute Coronary Syndrome
  • 相关文献

参考文献3

二级参考文献11

共引文献7

同被引文献11

  • 1曾高峰,刘格修,王燕,刘康桐,丁翠芬,匡希斌.纤溶酶原激活物抑制剂活性及其4G/5G基因多态性与急性冠状动脉综合征发病的关系[J].中国动脉硬化杂志,2005,13(6):760-762. 被引量:5
  • 2Oksjoki B, Kovanen PT, Pentikainen MO. Bole of complement activation in athemsclerosis [J]. Curt Opin Lipidol, 2003, 14 (5) : 477-482.
  • 3Oksjoki R, Jar'ca H, Kovanen PT, et al. Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation [ J ]. drterioscler Thromb Vasc Biol, 2003, 23 (4) : 630-636.
  • 4Giannakis E, Jokiranta TS, Male DA, et al. A common site within factor H SCR 7 responsible for binding heparin, C-reactive protein and streptococcal M protein [ J ]. Eur J lmmuno/, 2003, 33 (4) : 962-969.
  • 5PaiJK, Manson JE, Rexrode KM, etal. Complement factorH (Y402H) polyrnorphism and risk of eoronary heart disease in US men and women [ J]. European Heart J, 2007, 28 (11) : 1 297-303.
  • 6Kardys I, Klaver CC, Despriet DD, et al. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial in- farction: the Rotterdam Study [ J ]. J Am Coil Candid, 2006, 47 (8) : 1 568-575.
  • 7Qian Q, Chea Z, Ma G, et al. Complement factor H Y402H polymorphism, plasma concentration and risk of coronary artery disease [ J ]. Mol BiolRep, 2009, 36 (6): 1 257-261.
  • 8Zee RY, Diehl KA, Ridker PM. Complement factor H Y402H gene pol- ymorphism, C-reactive protein, and risk of incident myocardial infraction, isehaemic stroke, and venous thromboembolism: a nested case-control study [J]. Atherosclerosis, 2006, 187 (2) : 332-335.
  • 9Meng W, Hughes A, Patterson CC, et al. Genetic variants of complement factor H gene are not associated with premature coronar/heart disease: a family-based study in the Irish population [J]. BMC Med Goner. 2007.8: 62.
  • 10季翔,曲毅.CFH Y402H多态性与新生血管性年龄相关性黄斑变性的相关性[J].山东大学学报(医学版),2008,46(9):877-879. 被引量:2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部